Literature DB >> 7968439

Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging.

J A den Hollander1, W T Evanochko, G M Pohost.   

Abstract

Different approaches are being explored for the noninvasive observation of myocardial lipids in the human heart by in vivo 1H NMR spectroscopy. One approach is to measure cardiac lipids using a combination of volume selection and 2D gradient phase encoding. From these data sets lipid images can be reconstructed. By comparing these lipid images with 1H MR scout images, it is demonstrated that these signals represent epicardial and pericardial lipid. By selecting a smaller bar-shaped volume combined with 1D phase encoding or by using single volume techniques, it is possible to avoid most of the pericardial and epicardial lipid to obtain myocardial 1H NMR spectra of the human heart showing lipid signals, as well as trimethylamine and (phospho)creatine signals. These measurements demonstrate the feasibility of obtaining 1H NMR spectra of the human myocardium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968439     DOI: 10.1002/mrm.1910320205

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  21 in total

Review 1.  In-vivo cardiac studies in animals using magnetic resonance techniques: experimental aspects and MR readouts.

Authors:  M Rudin; P R Allegrini; N Beckmann; D Ekatodramis; D Laurent
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

Review 2.  Cardiac spectroscopy: techniques, indications and clinical results.

Authors:  Meinrad Beer
Journal:  Eur Radiol       Date:  2004-03-06       Impact factor: 5.315

3.  Insulin resistance is not associated with myocardial steatosis in women.

Authors:  M Krššák; Y Winhofer; C Göbl; M Bischof; G Reiter; A Kautzky-Willer; A Luger; M Krebs; C Anderwald
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

4.  Left ventricular fat deposition on CT in patients without proven myocardial disease.

Authors:  Eun-Ah Park; Whal Lee; Sang-Hoon Na; Jin Wook Chung; Jae Hyung Park
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-25       Impact factor: 2.357

5.  In vivo 1H-MR spectroscopy of the human heart.

Authors:  R Kreis; J Felblinger; B Jung; C Boesch
Journal:  MAGMA       Date:  1998-09       Impact factor: 2.310

6.  1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes.

Authors:  Francesco Secchi; Giovanni Di Leo; Marcello Petrini; Riccardo Spairani; Marco Alì; Marco Guazzi; Francesco Sardanelli
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

7.  Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

Authors:  Chia-Ying Liu; David A Bluemke; Gary Gerstenblith; Stefan L Zimmerman; Ji Li; Hong Zhu; Shenghan Lai; Hong Lai
Journal:  Int J Cardiol       Date:  2014-01-24       Impact factor: 4.164

8.  Early impairment of transmural principal strains in the left ventricular wall after short-term, high-fat feeding of mice predisposed to cardiac steatosis.

Authors:  Janusz H Hankiewicz; Natasha H Banke; Mariam Farjah; E Douglas Lewandowski
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-13       Impact factor: 7.792

9.  Myocardial Fat Imaging.

Authors:  Peter Kellman; Diego Hernando; Andrew E Arai
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-03-11

10.  Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.

Authors:  Eiryu Sai; Kazunori Shimada; Takayuki Yokoyama; Makoto Hiki; Shuji Sato; Nozomi Hamasaki; Masaki Maruyama; Ryoko Morimoto; Tetsuro Miyazaki; Shinichiro Fujimoto; Yoshifumi Tamura; Shigeki Aoki; Hirotaka Watada; Ryuzo Kawamori; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2016-05-03       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.